[ET Net News Agency, 1 September 2021] SINO BIOPHARM (01177) rose 2.92% to HK$6.7,
breaking above the 20-D SMA of HK$6.576.
It hits an intra-day high of HK$6.71, and an intra-day low of HK$6.42. The total shares
traded was 26.67 million, with a value of HK$175.32m. The active buy/sell ratio is 66:34,
with net buying turnover of HK$49.36m. DEUTSCHE SEC ASIA accounts for greatest net
responsive buying turnover of HK$2.62m, with volume weighted average price of HK$6.592.
UBS SEC accounts for greatest net responsive selling turnover of HK$5.11m, with volume
weighted average price of HK$6.584. The stock has risen a combined 7.37% over the past 3
consecutive trading days.
The Hang Seng Index now fell 12 points, or 0.05% to 25,866; the Hang Seng China
Enterprises Index now rose 44 points, or 0.49% to 9,228; the Hang Seng TECH Index now rose
86 points, or 1.3% to 6,693; with an overall turnover of HK$74.15b.
The SSE Composite Index now fell 1 points, or 0.04% to 3,542, with an overall turnover
of RMB422.58b.
The SZSE Component Index now fell 139 points, or 0.97% to 14,188, with an overall
turnover of RMB206.82b.
Basic Information
-------------------------------------------
Nominal 6.700 % Chg +2.92%
High 6.710 Low 6.420
Shares Tr 26.67m Turnover 175.32m
10-D SMA 6.431 %H.V 30.301
20-D SMA 6.576 VWAP 6.574
50-D SMA 6.893 RSI14 51.954
-------------------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 66:34, with net buying
turnover of HK$49.36m, rising a combined 7.37% over the past 3 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
SINO BIOPHARM (01177) 6.70 +2.92
SIHUAN PHARM (00460) 2.24 -3.03
CMS (00867) 15.16 -0.52
BAIYUNSHAN PH (00874) 19.96 +0.50
CSPC PHARMA (01093) 9.71 -1.62
3SBIO (01530) 8.52 -1.73
FOSUN PHARMA (02196) 50.50 +1.20
WUXI APPTEC (02359) 152.90 -1.35
HANSOH PHARMA (03692) 22.10 +4.00
PHARMARON (03759) 172.80 +0.12
-------------------------------------------------
(ed)